Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Iris Implantation Cyst	NCIT_C7761
Iris Cyst	NCIT_C3982	[An epithelium-lined cyst located in the iris.]
Stage II Lung Non-Small Cell Cancer AJCC v7	NCIT_C7777	[Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)]
Lung Non-Small Cell Cancer by AJCC v7 Stage	NCIT_C136491	[A term that refers to the staging of non-small cell lung carcinoma, following the rules of the TNM AJCC v7 classification system.]
Stage III Lung Non-Small Cell Cancer AJCC v7	NCIT_C7778	[Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)]
Superior Sulcus Lung Carcinoma	NCIT_C7779	[A carcinoma originating from the apical lung. Most superior sulcus lung carcinomas are bronchogenic carcinomas. This carcinoma may be associated with Pancoast syndrome. lt is also known as Pancoast tumor.]
Malignant Superior Sulcus Neoplasm	NCIT_C7527	[A malignant neoplasm originating from the apical lung. Most malignant superior sulcus neoplasms are bronchogenic carcinomas. This tumor may be associated with Pancoast syndrome. It is also known as Pancoast tumor.]
Stage II Gastric Cancer AJCC v6	NCIT_C7773	[Stage II includes: (T1, N2, M0), (T2a/b, N1, M0), (T3, N0, M0). T1: Tumor invades lamina propria or submucosa. T2: Tumor invades muscularis propria or submucosa. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. T3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures. N1: Metastasis in 1 to 6 regional lymph nodes. Metastasis in 7 to 15 regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.)]
Gastric Cancer by AJCC v6 Stage	NCIT_C90503
Stage III Gastric Cancer AJCC v6	NCIT_C7774	[Stage III includes: IIIA (T2a/b, N2, M0); (T3, N1, M0); (T4, N0, M0). IIIB: (T3, N2, M0). N0: No regional lymph node metastasis. N1: Metastasis in 1 to 6 regional lymph nodes. N2: Metastasis in 7 to 15 regional lymph nodes. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. T3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures. T4: Tumor invades adjacent structures. M0: No distant metastasis. (AJCC 6th ed.) - 2003]
Stage II Anal Canal Cancer AJCC v6 and v7	NCIT_C7775	[Stage II includes: (T2, N0, M0); (T3,N0, M0). T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.)]
Anal Canal Cancer by AJCC v6 and v7 Stage	NCIT_C133787	[A term that refers to the staging of anal canal cancer according to the American Joint Committee on Cancer, 6th and 7th editions. This staging system applies to carcinomas arising in the anal canal only; melanomas, carcinoid tumors, sarcomas, and perianal tumors are not included. (from AJCC 6th and 7th Eds.)]
Stage III Anal Canal Cancer AJCC v6 and v7	NCIT_C7776	[Stage III includes: IIIA (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0); IIIB (T4, N1, M0); (Any T, N2, M0); (Any T, N3, M0). T1: Tumor 2 cm or less in greatest dimension. T2: tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. T4: Tumor of any size that invades adjacent organ(s). N1: Metastasis in perirectal lymph node(s). N2: Metastasis in unilateral internal iliac and/or inguinal lymph node(s). N3: Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes. M0: No distant metastasis. (AJCC 6th and 7th Eds.)]
Stage IIIA Breast Cancer AJCC v7	NCIT_C7770	[Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.)]
Recurrent Carcinoma	NCIT_C7619	[The reemergence of a carcinoma after a period of remission.]
Stage I Gastric Cancer AJCC v6	NCIT_C7772	[Stage I includes: IA: (T1, N0, M0) and IB: (T1, N1, M0); (Ta/b, N0, M0). T1: Tumor invades lamina propria or submucosa. T2: Tumor invades the muscularis propria or the subserosa. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. N0: No regional lymph node metastasis. N1: Metastasis in 1 to 6 regional lymph nodes. N2: Metastasis in 7 to 15 regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.)]
Stage 0 Gastric Cancer AJCC v6 and v7	NCIT_C7788	[Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)]
Gastric Cancer by AJCC v7 Stage	NCIT_C91222	[A term that refers to the staging of gastric carcinoma according to the American Joint Committee on Cancer, 7th edition.]
Recurrent Adult Hodgkin Lymphoma	NCIT_C7789	[The reemergence of Hodgkin lymphoma in adulthood after a period of remission.]
Childhood Acute Lymphoblastic Leukemia	NCIT_C3168	[An acute lymphoblastic leukemia occurring during childhood. The majority of cases are B-acute lymphoblastic leukemias. Approximately 15% of the cases are T-acute lymphoblastic leukemias.]